Order Article Reprints

Turner BM, Finkelman BS, Hicks DG, Numbereye N, Moisini I, Dhakal A, Skinner K, Sanders MAG, Wang X, Shayne M, et al. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX^® Testing. Cancers. 2023; 15(3):903. https://doi.org/10.3390/cancers15030903

Turner, Bradley M., Brian S. Finkelman, David G. Hicks, Numbere Numbereye, Ioana Moisini, Ajay Dhakal, Kristin Skinner, Mary Ann G. Sanders, Xi Wang, Michelle Shayne, and et al. 2023. "The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX^® Testing" Cancers 15, no. 3: 903. https://doi.org/10.3390/cancers15030903

Turner, B. M., Finkelman, B. S., Hicks, D. G., Numbereye, N., Moisini, I., Dhakal, A., Skinner, K., Sanders, M. A. G., Wang, X., Shayne, M., Schiffhauer, L., Katerji, H., & Zhang, H. (2023). The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX^® Testing. Cancers, 15(3), 903. https://doi.org/10.3390/cancers15030903